These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Treatment of metronidazole-resistant Trichomonas vaginalis with tinidazole: case reports of three patients. Hager WD. Sex Transm Dis; 2004 Jun; 31(6):343-5. PubMed ID: 15167642 [Abstract] [Full Text] [Related]
4. In Vitro Effect of 5-Nitroimidazole Drugs against Trichomonas vaginalis Clinical Isolates. Mtshali A, Ngcapu S, Govender K, Sturm AW, Moodley P, Joubert BC. Microbiol Spectr; 2022 Aug 31; 10(4):e0091222. PubMed ID: 35863010 [Abstract] [Full Text] [Related]
6. Persistent and recurrent Trichomonas vaginalis infections: epidemiology, treatment and management considerations. Seña AC, Bachmann LH, Hobbs MM. Expert Rev Anti Infect Ther; 2014 Jun 31; 12(6):673-85. PubMed ID: 24555561 [Abstract] [Full Text] [Related]
7. In vitro metronidazole and tinidazole activities against metronidazole-resistant strains of Trichomonas vaginalis. Crowell AL, Sanders-Lewis KA, Secor WE. Antimicrob Agents Chemother; 2003 Apr 31; 47(4):1407-9. PubMed ID: 12654679 [Abstract] [Full Text] [Related]
8. A systematic review of the literature on mechanisms of 5-nitroimidazole resistance in Trichomonas vaginalis. Graves KJ, Novak J, Secor WE, Kissinger PJ, Schwebke JR, Muzny CA. Parasitology; 2020 Nov 31; 147(13):1383-1391. PubMed ID: 32729451 [Abstract] [Full Text] [Related]
13. Resistance of Trichomonas vaginalis to metronidazole: report of the first three cases from Finland and optimization of in vitro susceptibility testing under various oxygen concentrations. Meri T, Jokiranta TS, Suhonen L, Meri S. J Clin Microbiol; 2000 Feb 31; 38(2):763-7. PubMed ID: 10655382 [Abstract] [Full Text] [Related]
14. In Vitro Testing of Trichomonas vaginalis Drug Susceptibility: Evaluation of Minimal Lethal Concentrations for Metronidazole and Tinidazole That Correspond With Treatment Failure. Augostini P, Bradley ELP, Raphael BH, Secor WE. Sex Transm Dis; 2023 Jun 01; 50(6):370-373. PubMed ID: 36849257 [Abstract] [Full Text] [Related]
15. A case of metronidazole-resistant Trichomonas vaginalis in pregnancy. Forbes GL, Drayton R, Forbes GD. Int J STD AIDS; 2016 Sep 01; 27(10):906-8. PubMed ID: 26384945 [Abstract] [Full Text] [Related]
16. Successful treatment of trichomoniasis with tinidazole following desensitization in a patient allergic to metronidazole. Biagi M, Slipke W, Smalley A, Tsaras G. Int J STD AIDS; 2021 Jan 01; 32(1):89-91. PubMed ID: 33121364 [Abstract] [Full Text] [Related]
17. [In vitro susceptibility of Trichomonas vaginalis to metronidazole, ornidazole and proton pump inhibitors pantoprazole and esomeprazole]. Aksoy Gökmen A, Girginkardeşler N, Kilimcioğlu AA, Şirin MC, Özbilgin A. Mikrobiyol Bul; 2016 Jan 01; 50(1):133-9. PubMed ID: 27058337 [Abstract] [Full Text] [Related]
18. Tinidazole therapy for metronidazole-resistant vaginal trichomoniasis. Sobel JD, Nyirjesy P, Brown W. Clin Infect Dis; 2001 Oct 15; 33(8):1341-6. PubMed ID: 11565074 [Abstract] [Full Text] [Related]
19. A metronidazole-resistant strain of Trichomonas vaginalis and its sensitivity to Go 10213. Ray DK, Tendulkar JS, Shrivastava VB, Datta AK, Nagarajan K. J Antimicrob Chemother; 1984 Oct 15; 14(4):423-6. PubMed ID: 6334072 [Abstract] [Full Text] [Related]
20. In vitro susceptibility of Trichomonas vaginalis to metronidazole and treatment outcome in vaginal trichomoniasis. Müller M, Lossick JG, Gorrell TE. Sex Transm Dis; 1988 Oct 15; 15(1):17-24. PubMed ID: 3258675 [Abstract] [Full Text] [Related] Page: [Next] [New Search]